The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19

• Príomhchruthaitheoirí: Binbin Xia (Údar), Li Zheng (Údar), Yali Li (Údar), Wenfang Sun (Údar), Yang Liu (Údar), Liushui Li (Údar), Jingyao Pang (Údar), Jing Chen (Údar), Jiaxin Li (Údar), Hua Cheng (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Frontiers Media S.A., 2023-07-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

To effectively respond to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), an increasing number of researchers are focusing on the antiviral activity of cepharanthine (CEP), which is a clinically approved drug being used for over 70 years. This review aims to provide a brief overview of...